Effect of weight loss on ventricular repolarization in normotensive severely obese patients with and without heart failure

American Journal of the Medical Sciences

Volumn 349, Issue 1, 2015, Pages 17-23

  Alpert, Martin A ^a   Nusair, Maen B ^a   Mukerji, Rita ^a   Omran, Jad ^a   Mehra, Ankit ^a   Ardhanari, Sivakumar ^a   Kumar, Senthil A ^a   Terry, Boyd E ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Corrected QT interval; Corrected QT interval dispersion; Heart failure; Obesity; Ventricular repolarization; Weight loss

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD PRESSURE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART RATE; HEART REPOLARIZATION; HUMAN; HYPERTENSION; LEFT VENTRICULAR END SYSTOLIC WALL STRESS; LEG EDEMA; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; OBESITY; PROSPECTIVE STUDY; QT DISPERSION; QT INTERVAL; RENAL PROTECTION; SYSTOLIC BLOOD PRESSURE; VENTRICULAR REPOLARIZATION; WEIGHT REDUCTION; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; BARIATRIC SURGERY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84927943496     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/maj.0000000000000342     Document Type: Article

References (40)

1. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol 1993;72:23B-5B.
2. Malik M, Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000;36:1749-66.
3. Mukerji R, Petruc M, Fresen JL, et al. Effect of weight loss on left ventricular mass and ventricular repolarization in normotensive morbidly obese patients. Am J Cardiol 2012;110:415-9.
4. Bilora F, Vettore G, Barbata A, et al. Electrocardiographic findings in obese subjects. Minerva Gastroenterol Dietol 1999;45:193-7.
5. Girola A, Enrini R, Garbetta F, et al. QT dispersion in uncomplicated human obesity. Obes Res 2001;9:71-7.
6. Park JJ, Swan PD. Effect of obesity and regional adiposity on QTc interval in women. Int J Obes Relat Metab Disord 1997;21:1104-10.
7. Mizia-Stec K, Mandeki T, Zahorska-Markiewicz B, et al. The QT interval dispersion and ventricular late potential in obese women. Pol Merkur Lekarski 2000;8:84-6.
8. Arslan E, Yiginer O, Yavasoglu I, et al. Effect of uncomplicated obesity on QT interval in young men. Pol Arch Med Wewn 2010; 120:209-13.
9. Olivares Lopez JL, Vazquez Olivares M, Fleta Zarogozano J, et al. Electrocardiographic and echocardiographic findings in children with overweight and obesity. Med Clin (Barc) 2005;125:93-4.
10. Seyfeli E, Duru M, Kuvandik G, et al. Effect of weight loss on QTc dispersion in obese subjects. Anadoul Kardiyol Derg 2006;6:126-9.
11. Pietrobelli A, Rothacker D, Gallagher D, et al. Electrocardiographic QTc interval: short-term weight loss effects. Int J Obes Relat Metab Disord 1997;21:110-4.
12. Carella MJ, Mantz SL, Rovner DR, et al. Obesity, adiposity and lengthening of the QT interval: improvement after weight loss. Int J Obes Relat Metab Disord 1996;20:938-42.
13. Kanoupakis E, Stamatiou G, Melissas J, et al. Effects of weight loss on QT interval in morbidly obese patients. Obese Surg 2003;13: 869-73.
14. Russo V, Ammendola E, De Crescenzo I, et al. Effect of weight loss following bariatric surgery on myocardial dispersion of repolarization in morbidly obese patients. Obes Surg 2007;17:857-65.
15. Mshui ME, Saikawa T, Ito K, et al. QT interval and QT dispersion before and after diet therapy in patients with simple obesity. Proc Soc Exp Biol Med 1999;220:133-8.
16. Bezante GP, Scopinaro A, Papadia F, et al. Biliopancreatic diversion reduces QT interval and dispersion in severely obese patients. Obesity (Sliver Spring) 2007;15:1448-54.
17. Clarkson PB, Naas AA, McMahon A, et al. QT dispersion in essential hypertension. QJM 1995;88:327-32.
18. Ghanem Wisam MA, Murin J, Jaber J, et al. QT dispersion intervals in hypertensives with left ventricular hypertrophy. Vnitr Lek 2001;47: 20-4.
19. Salles GF, Cardoso CR, Deccache W. Multivariate associates of QT interval parameters in diabetic patients with arterial hypertension: importance of left ventricular mass and geometric patterns. J Hum Hypertens 2003;17:561-7.
20. Lonati LM, Magnaghi G, Bizzi C, et al. Patterns of QT dispersion in athletic and hypertensive left ventricular hypertrophy. Ann Noninvasive Electrocardiol 2004;9:252-6.
21. Alpert MA, Lambert CR, Terry BE, et al. Effect of weight loss on left ventricular mass in non-hypertensive morbidly obese patients. Am J Cardiol 1994;73:918-21.
22. Lavie CJ, Alpert MA, Arena R, et al. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 2013;1:93-102.
23. Mukerji R, Terry BE, Fresen JL, et al. Relation of left ventricular mass to QTc in normotensive severely obese patients. Obesity (Sliver Spring) 2012;20:1950-4.
24. Radman A, Murin J, Bulas J, et al. QT interval dispersion in hypertensive diabetics and in patients with hypertension with chronic heart failure without diabetes. Vnitr Lek 2003;49:802-7.
25. Davey PP, Bateman J, Mulligan IP, et al. QT interval dispersion in chronic heart failure and left ventricular hypertrophy: relation to autonomic nervous system and Holter tape abnormalities. Br Heart J 1994;71:268-73.
26. Bonnar EC, Davie AP, Caruana L, et al. QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion. Heart 1999;81:297-302.
27. Gunduz H, Akdemir R, Binak E, et al. Relation between stage of left ventricular diastolic dysfunction and QT dispersion. Acta Cardiol 2003; 58:303-8.
28. Grimm W, Steder U, Menz V, et al. QT dispersion and arrhythmic effects in idiopathic dilated cardiomyopathy. Am J Cardiol 1996;78:458-61.
29. Corbucci HA, Haber DM, Bestetti RB, et al. QT interval dispersion in patients with chronic heart failure secondary to Chaga's cardiomyopathy: correlation with clinical variables of prognostic significance. Cardiovasc Pathol 2006;15:18-23.
30. Kok-Meng Y, Pringle SD, Struthers AD. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. J Am Coll Cardiol 2001;37:1800-7.
31. Aksoy SM, Cay S, Cagirci G, et al. Nebivolol therapy improves QTc and QTc dispersion parameters in heart failure patients. Cardiovasc J Afr 2012;23:191-3.
32. Maltsev VA, Silverman N, Sabbah HN, et al. Chronic heart failure slows late sodium current in human and canine ventricular myocytes: implications for repolarization variability. Eur J Heart Fail 2007;9: 219-27.
33. Barr CS, Naas A, Freeman M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-9.
34. Mckee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure. N Engl J Med 1971;285:1441-6.
35. Russell AE, Wing LM, Smith SA, et al. Optimal size of cuff bladder in indirect measurement of arterial pressure in adults. J Hypertens 1989;7: 607-13.
36. Gottdiener JS, Bednarz J, Devereux R, et al. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004;17:1086-119.
37. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison with necropsy findings. Am J Cardiol 1986;57:450-8.
38. Lauer MJ, Anderson KM, Larson MG, et al. A new method for indexing left ventricular mass for differences in body size. Am J Cardiol 1994;74:487-91.
39. Foppa M, Duncan BB, Rohde LEP. Echocardiographic left ventricular mass estimation. How should we define hypertrophy? Cardiovasc Ultrasound 2005;3:17.
40. Van Noord C, Eigelsheim M, Stricker BH. Drug and non-drug associated QT interval prolongation. Br J Clin Pharmacol 2010;70:16-23.